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ABSTRACT
Deregulation of the Wnt/b-catenin signaling
pathway is a hallmark of colon cancer. Mutations
in the adenomatous polyposis coli (APC) gene
occur in the vast majority of colorectal cancers
and are an initiating event in cellular transformation.
Cells harboring mutant APC contain elevated levels
of the b-catenin transcription coactivator in the
nucleus which leads to abnormal expression of
genes controlled by b-catenin/T-cell factor 4
(TCF4) complexes. Here, we use chromatin
immunoprecipitation coupled with massively
parallel sequencing (ChIP-Seq) to identify b-catenin
binding regions in HCT116 human colon cancer
cells. We localized 2168 b-catenin enriched regions
using a concordance approach for integrating the
output from multiple peak alignment algorithms.
Motif discovery algorithms found a core TCF4
motif (T/A–T/A–C–A–A–A–G), an extended TCF4
motif (A/T/G–C/G–T/A–T/A–C–A–A–A–G) and an
AP-1 motif (T–G–A–C/T–T–C–A) to be significantly
represented in b-catenin enriched regions.
Furthermore, 417 regions contained both TCF4 and
AP-1 motifs. Genes associated with TCF4 and AP-1
motifs bound b-catenin, TCF4 and c-Jun in vivo and
were activated by Wnt signaling and serum growth
factors. Our work provides evidence that Wnt/
b-catenin and mitogen signaling pathways intersect
directly to regulate a defined set of target genes.
INTRODUCTION
The Wnt/b-catenin signaling pathway is required for
homeostasis in the gastrointestinal (GI) tract (1). The GI
tract is coated with small invaginations, or crypts, which
are comprised of discrete zones of proliferating and
diﬀerentiated cells (1). Wnt signaling maintains the prolif-
erative compartment of the crypt. The b-catenin tran-
scriptional coactivator controls downstream genetic
programs elicited by Wnt signaling and its cellular levels
are tightly regulated (2,3). When cells are not exposed to
Wnt, cytosolic b-catenin associates with a multi-protein
complex that contains the adenomatous polyposis coli
(APC) protein. APC functions as a scaﬀold to coordinate
b-catenin phosphorylation and degradation by the prote-
asome. Under these conditions, Wnt/b-catenin target
genes are silenced by corepressor complexes that are
tethered to Wnt responsive DNA enhancers (WREs)
through interactions with the T-cell factor (TCF) family
of transcription factors (4). TCF4 is a predominant TCF
family member in colon cancer cells (5). When cells are
exposed to Wnt, b-catenin escapes proteasomal degrad-
ation, and is chaperoned to the nucleus by APC.
There, it occupies TCF4 bound WREs and displaces
the corepressors. b-catenin then recruits chromatin-
modifying complexes and Wnt/b-catenin target genes are
expressed (4).
Deregulation of the Wnt/b-catenin pathway is
associated with colon carcinogenesis (2,3). In virtually
all cases of colon cancer, mutations target components
of the Wnt signaling pathway (6). The most common
lesions localize to APC and lead to production of a
truncated APC protein that can no longer eﬀectively
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the earliest stages of carcinogensis when normal colonic
epithelial cells are transformed into aberrant crypt foci (6).
Inherited APC mutations give rise to familial adenoma-
tous polyposis, a disease where aﬄicted individuals are
burdened by thousands of intestinal polyps early in adult-
hood (7,8). In the rare cancer cases where APC is
wild-type, mutations instead are found in CTNNB1
(3,9,10). CTNNB1 is the gene that encodes b-catenin,
and the cancer causing lesions map to positions near the
50 portion of the gene. These mutations give rise to a
b-catenin pool that is resistant to proteasomal degrad-
ation (11). In each instance, mutations that target APC
or CTNNB1 lead to high levels of b-catenin in the nucleus
and abnormal expression of genes regulated by b-catenin/
TCF4 complexes (5,9). Therefore identifying target genes
directly controlled by b-catenin/TCF4 is required to
understand the pathogenesis of this disease.
To identify direct b-catenin/TCF4 target genes it is ﬁrst
necessary to map binding sites for these factors across the
genome. Previously, we used an unbiased and
genome-wide screen termed serial analysis of chromatin
occupancy (SACO) to localize 412 high conﬁdence
b-catenin binding sites in the human colorectal cancer
cell line, HCT116 (12). Approximately half of the
binding sites were near (<2.5kb) or within protein-coding
gene boundaries. These b-catenin binding sites were
located in 50 promoter regions, intragenic regions and 30
untranslated regions. b-Catenin binding to 30 positions
relative to E2F4 and MYC genes identiﬁed functional
WREs. For E2F4, the downstream enhancer drove expres-
sion of an antisense and non-coding transcript that
decreased E2F4 protein levels (13). For MYC, b-catenin
occupancy of the downstream enhancer initiated a chro-
matin loop that integrated the 50 WRE to coordinate
MYC expression in response to Wnt/b-catenin and
mitogen signaling pathways (14,15). Recently, Hatzis
et al. (16) used chromatin immunoprecipitation (ChIP)
coupled with microarrays (ChIP-chip) to localize 6868
TCF4 binding sites in L171 colorectal cancer cells (16).
As was the case for b-catenin, TCF4 binding was also
found throughout protein coding gene boundaries.
Together these studies indicate that Wnt activation of
target gene expression is mechanistically more intricate
than the simple model involving recruitment of b-catenin
to TCF4-bound 50 promoter regions.
While SACO was a pioneering technique used to
identify transcription factor binding sites and was a
viable alternative to the ChIP-chip approach, it did, like
most methodologies, suﬀer from some limitations. First,
SACO libraries were constructed in plasmid vectors and
then sequenced using high-throughput and Sanger-based
sequencing. This was both laborious and costly. In
addition, large DNA fragments were included in construc-
tion of the earliest SACO libraries. While most DNA was
in the 500–700bp range, fragments as large as 2.5kb were
included in the b-catenin SACO library. This impinged
upon the resolution of the technique and hindered
de novo motif discovery within b-catenin bound loci. A
successor to SACO is the recently described ChIP
coupled with massively parallel sequencing (ChIP-Seq)
approach (17–19). In this technique, DNA puriﬁed from
immunoprecipitated chromatin is size-selected and then
sequenced using one of the next-generation sequencing
platforms such as the Illumina genome analyzer (18,19).
The robustness, cost, resolution and relative ease in library
construction has made ChIP-seq, rather than SACO, a
current method of choice for genome-wide localization
of transcription factor binding sites. ChIP-Seq has been
used to map numerous histone modiﬁcations (20) and
binding sites for several transcription factors including,
but not limited to, NRSF/REST, GATA1, SRF, E2F4,
E2F6 and STAT1 (17). In addition, ChIP-Seq has been
used recently to identify TCF4 enriched binding regions in
human colon cancer cell lines (21,22). Tuupanen et al. (22)
identiﬁed 10 TCF4-site containing regions in LoVo cells
using a combination of ChIP-Seq and the enhancer
element locator analysis. Blahnik et al. (21) used
ChIP-Seq to identify 21102 TCF4 binding sites in
HCT116 cells.
In this report we used ChIP-Seq to identify b-catenin
binding regions in HCT116 human colon cancer cells. We
chose this high-resolution and genome-wide approach
because we were interested in using de novo motif
analysis to identify transcription factors that putatively
cooperate with b-catenin/TCF4. Many algorithms exist
to map the enriched genomic regions identiﬁed in a
ChIP-Seq experiment (23). Because each approach varies
in computational strategy and can produce dramatically
diﬀerent numbers of enriched regions for a given false
discovery rate (FDR) cutoﬀ, there is some debate as to
which is the preferred algorithm (18). In this report, we
used CisGenome (24), SISSRs (25) and WTD (26) to ini-
tially identify enriched regions from the b-catenin
ChIP-Seq library. Based on the intersection of regions
found in common with each algorithm, we identiﬁed
2168 b-catenin enriched regions. Consistent with our
previous report (12), we found over-representation of the
core and evolutionarily conserved TCF4 consensus motifs
within enriched regions. In addition, we found that con-
sensus AP-1 motifs were also over-represented in a large
subset of the enriched regions with the majority of these
motifs co-occurring with a TCF4 motif. Finally, we show
that serum mitogens and Wnt signaling agonists coopera-
tively activate expression of some target genes in proxim-
ity to b-catenin bound loci that contain AP-1 and TCF4
motifs. These ﬁndings indicate that a discrete subset of
b-catenin target genes are activated by mitogen and Wnt
signaling in colon cancer cells, and that this regulation
likely occurs through consensus AP-1 and TCF4 sites,
respectively.
MATERIALS AND METHODS
Cell culture
HCT116 human colorectal cancer cells (ATCC number
CCL-247) were cultured as previously described (14).
ChIP
Antibodies used in ChIP assays included: 3mg of anti-
b-catenin (BD transduction, 610154), 3mg of anti-TCF4
5736 Nucleic Acids Research, 2010,Vol.38, No. 17(Millipore, 05-511), 2ml of anti-c-Jun (Millipore, 06-225)
and 6mg rabbit anti mouse IgG (Jackson Immunoresearch,
315-005-003). b-Catenin ChIP DNA for the ChIP-Seq
library was prepared using the Chromatin
Immunoprecipitation Assay Kit (Millipore, 17-295) ac-
cording to the instructions. To assess b-catenin, TCF4
and c-Jun binding to ChIP-Seq peak loci, ChIP assays con-
tained 5–10 10
6 cells and were conducted as previously
reported (13). Chromatin in formaldehyde ﬁxed cell lysates
was sonicated to an average size of 500–700bp using a
Misonix Ultrasonic XL-2000 Liquid Processor (5 20s,
output wattage 7, with 45s rest intervals on ice between
pulses). Real time PCR was used to detect isolated ChIP
fragments and samples contained 10mlo f2  iQ SYBR
Green Supermix (Bio-rad, 170-882), 0.25mM of each
primer and 3ml of puriﬁed ChIP DNA. Reactions were
processed for one cycle at 94 C for 3min, then 45 cycles
at 94 C for 10s and at 68 C for 40s using a MyIQ Single
Color Real-Time PCR machine (Bio-rad). Primers were
designed, using Primer3 software, to a 600bp DNA
segment that was centered on the b-catenin ChIP-Seq
coverage region. Primers used in this study are listed in
Supplementary Table S7. Real time data is represented as
fold levels over control. The control is a distal region that
is 5kb upstream from the MYC transcript start site that
does not bind signiﬁcant levels of b-catenin, TCF4 or
c-Jun (14).
Construction of the ChIP-Seq library
b-Catenin precipitated and puriﬁed ChIP DNA (350ng)
was processed using the ChIP-Seq DNA Sample
Preparation Kit (Illumina, 1003473) according to instruc-
tions provided by the manufacturer. Prior to sequencing,
DNAs were re-quantiﬁed using a NanoDrop 1000
Spectrophotometer and the quality of DNA was
assessed using a Bioanalyzer DNA 1000 (Agilent).
Samples were diluted to 10nM and 54-nt reads were
obtained from one lane of sequencing on a Illumina GA
II sequencer. The High Throughput Sequencing Facility at
the University of Oregon (http://htseq.uoregon.edu)
sequenced the library. Raw sequence data was submitted
to the sequence read archive (SRA) under accession
number SRA012054.
Realignment of ChIP-Seq reads
Reads (9322654) were sequenced and of these, 8 456 287
passed the quality ﬁlter as assessed using ELAND
software (Illumina). We then used ELAND to align the
8 456 267 reads to the repeat masked NCBI 36/hg18 build
of the human genome. We assigned unique positions for 6
576 033 reads allowing up to two mismatches in the ﬁrst
32 bases of the read sequence. This set of reads was
retained for downstream computational analysis.
Identiﬁcation of b-catenin enriched regions
We utilized three peak calling programs to deﬁne a set of
putative binding regions: CisGenome (24), SISSRs (25)
and WTD (26). Each method implements variations on
a sliding window approach to identify regions of higher
read depth, referred to as peaks, relative to a background
distribution. Based on the particular algorithm, back-
ground distributions are derived using reads from a
negative control experiment, through monte carlo proced-
ures, or through statistical models (23). CisGenome and
SISSRs rely on statistical model ﬁtting while the WTD
method uses a randomization approach. SISSRs was run
using a window size of 20 bases with the FDR set at 0.01.
WTD was run with the window size estimated from the
binding characteristics. Any local tag anomalies were
removed and an FDR cutoﬀ of 0.01 was assessed using
10 randomization procedures. CisGenome was run using a
window size of 100 and a read cutoﬀ of 7 reads. We then
identiﬁed the midpoints of each of the regions and
extended 299bp upstream and 300bp downstream so
that there was a total of 600bp identifying each putative
binding region. We chose 600 bases because it was twice
what we considered to be the largest size of DNA frag-
ments submitted for sequencing (Figure 1B). Using these
criteria, CisGenome, SISSRs and WTD called 100 372, 80
733 and 2940 peak regions, respectively. Peaks called in
common by the three algorithms yielded 2168 putative
b-catenin binding regions and this set was used for
further computational analysis (See Supplementary
Table S1 for a summary of peak overlaps).
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Figure 1. Generation of a b-catenin ChIP-Seq library in HCT116
human colorectal carcinoma cells. (A) Real-time PCR analysis of
DNA fragments isolated from a ChIP assay using a b-catenin speciﬁc
antibody. Speciﬁc oligonucleotides were used to detect binding to a
WRE downstream of the MYC transcription stop site (14,15). A
region 5kb upstream from the MYC promoter that does not associate
with b-catenin/TCF4 complexes (Ctrl) served as a negative control (14).
Data is presented as fold-binding relative to control and error is SEM.
(B) Agarose gel analysis of size selected and PCR ampliﬁed b-catenin
ChIP DNA used for Illumina high-throughput sequencing. S is a DNA
standard and Ctrl is a negative control for PCR ampliﬁcation (see
‘Materials and Methods’ Section). (C) Schematic of the MYC locus.
Thin rectangles are untranslated regions, thick rectangles are exons,
thin lines are introns and the arrow is the transcription start site.
Gray shaded boxes are b-catenin enriched regions that were identiﬁed
in the ChIP-Seq library which overlap 50,3 0 and  335kb WREs
(14,22,29). Peak density plots for b-catenin enriched regions are
depicted below the WREs.
Nucleic Acids Research, 2010,Vol.38, No. 17 5737Generation of peak images
Images of the peaks were generated using the SPP package
(26). Total read counts were smoothed using a Gaussian
kernel with a step size of 50 and a bandwidth of 200.
Values were written to a WIG ﬁle and visualized in the
UCSC genome browser.
De novo motif analysis
The genomic sequence (600bp) encompassing each
enriched region was isolated and the regions were
separated into two sets based upon whether they had at
least one instance of a canonical (T/A–T/A–C–A–A–A–
G) or evolutionarily conserved (A–C/G–T/A–T–C–A–A–
A–G) TCF4 motif within the boundaries of the region
(16). The reverse complements of these sequences were
also included. The sequence from each region was repeat
masked and used as input into the Gibbs sampler motif
ﬁnding program provided by CisGenome. The motif
ﬁnder was run searching for motifs of 7, 11 and 15bp
using 5000 MCMC iterations and a score was produced
for each motif. Control sequences were picked based on
the strategy of Ji et al. (27). Brieﬂy, sequences were chosen
to match the underlying characteristics of the enriched
regions. Each control sequence was picked randomly
such that it was of the same size and was in the same
position relative to the nearest RefSeq transcript (28) as
a given enriched region. Five sets of control sequences
were chosen in this manner for both sets of enriched
regions. Motifs found from the de novo search were
mapped back to both the b-catenin enriched regions and
the control sequences using the motif mapping tool from
CisGenome. The number of matches were based on a like-
lihood ratio cutoﬀ of 500 and a background model
consisting of a third-order markov chain, in accordance
with Ji et al. (27). The relative enrichment was computed
as described (27). Motifs that had a relative enrichment
score >2 were determined to be over-represented in the
b-catenin enriched regions.
Chromatin conformation capture
Chromatin conformation capture (3C) assays were con-
ducted as described (15) with minor modiﬁcations.
Formaldehyde cross linked chromatin was digested over-
night with 40ml (800U) of XbaI (New England Biolabs).
XbaI was then heat-inactivated at 65 C for 20min prior to
ligation reactions. After proteinase K treatment, the
samples were extracted in phenol/chloroform three
times, followed by three back extractions with chloroform.
The chromatin loop at CXXC5 was detected by PCR
using primers C51, GTACGTAGTCGTTTTAGCC and
C56, GCACCCAGCCTCTCAAACCC and the condi-
tions previously described (15). To control for loading,
parallel samples were ampliﬁed by PCR with the tubulin
speciﬁc primers GGGGCTGGGTAAATGGCAAA and
TGGCACTGGCTCTGGGTTCG. Products were
analyzed on a 1% agarose gel by electrophoresis,
puriﬁed and sequenced.
Serum and LiCl stimulation of HCT116 cells
HCT116 cells were synchronized in the cell cycle as previ-
ously described (14). For ChIP experiments, G0/G1 cells
grown in a 10-cm tissue culture dish were stimulated with
medium containing 10% fetal bovine serum for 1 or 2h
prior to formaldehyde ﬁxation. For expression analysis,
G0/G1 cells were grown in a 6-well plate prior to stimula-
tion with medium containing serum with and without
10mM LiCl for 1 or 4h as indicated.
Reverse transcription/real time PCR
RNA was isolated using TRIZol reagent (Invitrogen,
15596-018) according to the instructions. cDNA was
synthesized using 500ng of total RNA and the iScript
cDNA Synthesis Kit (Bio-rad, 170-8890) according to
the instructions. cDNA was diluted to 1: 150 before quan-
tiﬁcation by real-time PCR. Real-time PCR was con-
ducted as outlined under the ChIP section, except 3mlo f
diluted cDNA was used as the template. Primers were
designed using Primer3 software and their sequences are
included in Supplementary Table S7.
RESULTS
Construction of the b-catenin ChIP-Seq library
We were interested in using ChIP coupled with massively
parallel sequencing (ChIP-Seq) to identify b-catenin
binding regions in HCT116 human colon cancer cells.
Prior to constructing the library, we tested the eﬃcacy
of our ChIP protocol to identify bona ﬁde b-catenin
targets in this cell line. b-catenin strongly associated
with a WRE located 1.4kb downstream of the transcrip-
tion stop site of the c-Myc gene (MYC) as we have
reported previously (Figure 1A) (14,15). Furthermore, in-
signiﬁcant levels of b-catenin were detected at a control
element located 5kb upstream of the MYC transcription
start site that did not associate with either b-catenin or
TCF4 (Figure 1A) (14). Size-selected b-catenin ChIP
DNA was then processed according to the Illumina
sample preparation protocol and minimally ampliﬁed by
PCR. Most ampliﬁed fragments were in the range of 175–
225bp and were produced in samples containing b-catenin
ChIP DNA whereas these products were absent in the
control sample (Figure 1B). A total of 9322654 reads
were generated from one lane of sequencing using an
Illumina GA II high throughput sequencer. Of these,
 90.7% (8456287) passed the quality ﬁlter and  77.8%
(6 576 033) reads were assigned a unique position in the
human genome. The set of 6 576 033 reads was then sub-
jected to additional computational analysis.
As outlined in the ‘Materials and Methods’ section, we
compared three computational algorithms and we con-
sidered the peaks called in common to demarcate
putative b-catenin binding regions. This approach
yielded 2168 peaks that we termed b-catenin enriched
regions. The genomic boundaries of these regions are
provided in Supplementary Table S2. To determine
whether our approach identiﬁed bona ﬁde Wnt/b-catenin
target genes, we searched for representation of the MYC
5738 Nucleic Acids Research, 2010,Vol.38, No. 17gene. b-catenin enriched regions coincided with the 50,3 0
and distal WREs previously shown to regulate MYC ex-
pression (Figure 1C) (15,22,29–31). Thus, our approach
identiﬁed b-catenin associated WREs in colon cancer cells.
Computational analysis of b-catenin enriched regions
We next localized the b-catenin enriched regions relative
to transcripts deposited in the reference sequence database
(RefSeq) (28). Of the 2168 b-catenin enriched regions,
1562 (72%) were within 50kb of a RefSeq transcript.
Upon further analysis, we found that 1219 (56%) were
within 10kb and 1090 (50%) were within 2.5kb
(Figure 2A). With respect to protein-coding genes and in
agreement with our previous ﬁndings (12), we found that
b-catenin preferentially localized to internal positions or
those positions that are downstream from the transcrip-
tion start site and upstream from the transcription stop
site (Figure 2B). There was a tendency for b-catenin
enriched regions within 2.5kb of the 50 gene boundary
to cluster around transcriptional start sites (Figure 2C).
The genes containing b-catenin enriched regions near
(<2.5kb) or within gene boundaries are listed in
Supplementary Table S3. Overall, the 1090 b-catenin
enriched regions are near or within 988 genes.
It was recently shown that a distal WRE interacted with
MYC through a large chromatin loop (30,31). This was
the ﬁrst demonstration indicating that a WRE positioned
hundreds of kilobases away from their target genes func-
tioned as a transcriptional enhancer. To further explore
the relationship of b-catenin enriched regions and
annotated protein-coding transcripts, we determined the
empirical cumulative distribution function (CDF) of the
distance from each b-catenin enriched region to the
nearest transcript. This analysis found that 80% of
enriched regions were within 100kb of an annotated tran-
script and that 95% were within 450kb (Figure 2D).
Together these ﬁndings indicate that while most
b-catenin regions are near or within protein-coding
genes, 28% localized at a distance of >50kb away.
Furthermore, localization of b-catenin enriched regions
with gene boundaries was statistically signiﬁcant when
compared to localization of a control set of regions with
gene boundaries (Supplementary Figure S1).
b-Catenin occupancy of 50 and 30 regions at CXXC5
identiﬁed a chromatin loop
Recently we described a b-catenin and TCF4-coordinated
chromatin loop at MYC that integrated 50 and 30 proximal
WREs (15). To identify targets that may be likewise
regulated, we searched for genes that contained both 50
and 30 b-catenin enriched regions. In addition to MYC,
we found two genes, CXXC5 and FXR2, that contained
b-catenin enriched regions within 2.5kb of both transcript
boundaries (Supplementary Table S4 and Figure 3A). If
the range was expanded to include regions 10kb from the
50 and 30 ends, 11 loci were identiﬁed. This number
increased to 111 loci if the range was further expanded
to 50kb. We ﬁrst used ChIP and real-time PCR to deter-
mine whether b-catenin occupied the identiﬁed regions
relative to CXXC5. b-catenin precipitated higher levels
of the 50 and 30 CXXC5 enriched regions relative to
control (Figure 3B). We then used chromatin conform-
ation capture (3C) to determine whether a chromatin
loop containing the 50 and 30 b-catenin associated
regions formed at CXXC5 (32). Figure 3A depicts the pos-
itions of the XbaI restriction endonuclease sites and PCR
primer locations used to interrogate CXXC5 in 3C assays.
A PCR product of the correct size was generated with
forward primer C51 and reverse primer C56, and its pro-
duction was dependent upon the addition of XbaI and
DNA ligase to the reaction (Figure 3C). This 341bp
fragment was sequenced and conﬁrmed to be the correct
CXXC5 product (Figure 3D). This analysis indicated that
a chromatin loop containing b-catenin bound 50 and 30
WREs is present at CXXC5 in human colon cancer cells.
Motif analysis of b-catenin enriched regions
Genome-wide binding analysis has indicated that most
b-catenin recruitment to chromatin in colon cancer cells
likely occurred through interactions with TCF4 (12).
Therefore, we ﬁrst determined whether the b-catenin
enriched regions contained a canonical TCF4 motif
(T/A–T/A–C–A–A–A–G) or the evolutionarily conserved
TCF4 motif (A–C/G–T/A–T–C–A–A–A–G) (16). Of the
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Figure 2. Distribution of b-catenin enriched regions within the
ChIP-Seq library. Sequenced DNA fragments that passed quality
control were mapped to the NCBI 36/hg18 build of the human
genome using ELAND software. b-catenin enriched regions were
identiﬁed as described in the methods. (A) Histogram showing the per-
centage of enriched regions that localized within 2.5, 10 or 50kb of a
protein-coding gene boundary as deﬁned by the RefSeq library (28). (B)
Histogram representing percentage of enriched regions that localized
upstream (50), within (internal) or downstream (30) of a RefSeq gene.
For 50 and 30 categorizations, the enriched regions were <2.5kb from
each respective boundary. (C) Density plot depicting the distribution of
enriched regions that are ±2.5kb from a RefSeq transcription start
site. (D) Empirical CDF plot representing the distance of each
b-catenin enriched region to its nearest protein-coding gene
boundary. The gray vertical line indicates 50kb.
Nucleic Acids Research, 2010,Vol.38, No. 17 57392168 enriched regions, 1026 (47%) contained at least one
TCF4 motif. A fraction of these, 192 (9%), resembled the
longer and evolutionarily conserved variant. We then per-
formed de novo motif analysis on these populations using
a Gibbs sampler algorithm (24,27). Over-representation of
motifs was determined by computing the relative enrich-
ment measure as described in the ‘Materials and Methods’
section (27). Using the 1026 enriched-regions that con-
tained TCF4 consensus sequences, we successfully
identiﬁed an over-representation of both the core and evo-
lutionarily conserved TCF4 motifs. This indicated that
our de novo search approach was valid. Upon further
analysis, we found a striking co-enrichment of AP-1
motifs with the consensus TCF4 motifs. Examples of all
three motifs, along with their scores and enrichment
values relative to control sequences, are shown in
Figure 4A. Overall, 417 b-catenin enriched regions con-
tained a TCF4 and an AP-1 motif (Figure 4B and
Supplementary Table S5).
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Figure 3. A chromatin loop containing 50 and 30 b-catenin enriched
regions is detected at the CXXC5 gene. (A) Schematic of the CXXC5
locus with untranslated regions as thin rectangles, introns as thin lines,
exons as thick rectangles and an arrow demarcating the transcription
start site. The peak density plots below the gene represent b-catenin
enriched regions identiﬁed in the ChIP-Seq library. The triangles and
stunted arrows identify the XbaI sites and PCR primers, respectively,
used in the chromatin conformation capture (3C) assay depicted in (C).
(B) Real time PCR analysis of b-catenin ChIP assays performed in
HCT116 cells. Speciﬁc oligonucleotides were used to detect b-catenin
binding to enriched regions depicted by gray rectangles in (A). 50 is the
upstream site and 30 is the downstream site. A distal upstream region of
the MYC gene was used as a negative control (Ctrl). Error bars are
SEM. (C) Agarose gel of PCR products generated from a 3C analysis
of CXXC5 in HCT116 cells. Generation of the 3C product (CXXC5
5030) with primers C51 and C56 required the addition of XbaI and
ligase to the reactions. LC is a loading control and S is a DNA
standard. (D) DNA sequence of the 3C product. Arrows denote
primer sequences C51 and C56 and the XbaI site are boxed.
5740 Nucleic Acids Research, 2010,Vol.38, No. 17The coupling of AP-1 and TCF4 motifs in 417 (19%)
b-catenin enriched regions suggested that AP-1, TCF4 and
b-catenin may co-regulate target gene expression. To
address this hypothesis, we used the ChIP assay to deter-
mine whether these factors bound regions containing AP-1
and TCF4 motifs. We ﬁrst tested b-catenin binding to a
selected subset of regions associated with 23
protein-coding genes. For this set of genes, associated
regions were those that localized within 2.5kb from gene
boundaries. b-catenin occupied 19 sites in asynchronously
growing HCT116 cells (Figure 5A). We then assayed the
same regions for TCF4 binding using TCF4 speciﬁc
antibodies in the ChIP assay. TCF4 bound the same 19
targets as b-catenin (Figure 5B). We concluded from this
analysis that b-catenin and TCF4 co-occupied target genes
containing TCF4 and AP-1 consensus motifs.
Next, we determined whether AP-1 bound to these
selected regions. AP-1 is a heterodimeric complex
comprised of Fos and Jun transcription factors (33,34).
AP-1 regulates key cellular processes such as proliferation,
diﬀerentiation and apoptosis (35). Several groups have
shown that c-Jun associates with AP-1 consensus motifs
in colon cancer cells (14,36–39). We therefore tested
whether c-Jun occupied b-catenin enriched regions con-
taining AP-1 and TCF4 motifs. Using c-Jun antibodies
in ChIP assays conducted in asynchronously growing
HCT116 cells, we found that c-Jun associated with 14 of
the 19 regions that bound b-catenin and TCF4
(Figure 5C). Serum mitogens elicit signal transduction
pathways that stimulate c-Jun binding to chromatin. We
have previously shown that c-Jun occupancy of the MYC
30 enhancer increased as quiescent cells re-entered the cell
cycle in response to serum (14). We therefore determined
whether treatment of quiescent cells with serum would
stimulate c-Jun association with the ﬁve targets that
lacked binding in asynchronous cells. HCT116 cells were
grown to conﬂuency in serum-depleted medium for two
days, which caused these cells to enter the G0/G1 stage of
the cell cycle (14,39). Cells were then treated with medium
containing serum for 1 or 2h and c-Jun ChIP assays were
conducted. In line with previous ﬁndings, higher levels of
c-Jun were found at the MYC 30 enhancer when
synchronized cells were exposed to serum for 1h as
compared to levels detected in quiescent cells
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Figure 5. b-catenin enriched regions containing AP-1 and TCF4 motifs associated with b-catenin, TCF4 and c-Jun. (A) Real-time PCR analysis of a
ChIP assay conducted with b-catenin speciﬁc antibodies in HCT116 cells. Binding to enriched regions containing TCF4 and AP-1 consensus motifs
was detected using speciﬁc oligonucleotides. MYC is the MYC 30 WRE and Ctrl. is a control region 5kb upstream of the MYC transcription start
site (14). Data is presented as fold binding over control and error is SEM. In (B) and (C) ChIP assays were performed using anti-TCF4 or anti-c-Jun
speciﬁc antibodies, respectively. (D) Serum-deprived HCT116 cells were cultured in media containing serum for 1 or 2h as indicated prior to ChIP
with c-Jun speciﬁc antibodies.
Nucleic Acids Research, 2010,Vol.38, No. 17 5741(Figure 5D) (14). When c-Jun binding was interrogated at
the ﬁve ChIP-Seq targets, serum induced occupancy at
regions associated with RNF43, GAS7, PINX1 and
HABP4 (Figure 5D). RAD51L1 did not associate with
c-Jun. Thus in total, 18 of the 19 b-catenin enriched
regions containing TCF4 and AP1 motifs associated
with b-catenin, c-Jun and TCF4.
We then tested whether Wnt/b-catenin and mitogen sig-
naling pathways converged to activate genes bound by
AP-1, b-catenin and TCF4. First, we proﬁled RNA
levels for 15 genes in asynchronously dividing HCT116
cells using reverse transcription coupled to real-time
PCR. Expression of each gene was readily detected with
GAS7 and GPR55 expressed at reduced levels (Figure 6A).
As these cells contain high levels of nuclear b-catenin and
are cultured in medium containing serum, this result does
ascertain the relative contribution of mitogen and Wnt/
b-catenin pathways to gene expression per se. We con-
ducted the following experiment to address this question
more precisely. HCT116 cells were ﬁrst arrested in G0/G1
stage of the cell cycle by culturing in serum-depleted
media. We then added medium containing serum with or
without 10mM LiCl for 1 or 4h. LiCl is a well-established
agonist of the Wnt/b-catenin pathway as it inhibits
GSK3b and stimulates nuclear b-catenin accumulation
(13,40,41). We and others have shown that LiCl increased
b-catenin levels in HCT116 cells (13,42,43). Therefore, we
predicted that if mitogen and Wnt/b-catenin signaling
pathways converged to regulate gene expression, treat-
ment with serum and LiCl would result in increased tran-
script levels when compared to treatment with serum
alone. LiCl increased mitogen-induced expression of
MYC, PDE4B, DDR2, CTBP2, EGFR, DNAJB1,
WISP1 and PINX1 (Figure 6B). HDAC4, PCDH7 and
HABP4 were activated by serum alone, and MMP20,
CYP39A1 and YAP1 genes were not induced above
levels seen in serum-deprived cells (Figure 6B). Together
this analysis indicated that Wnt/b-catenin and
mitogen-signaling pathways directly activate a subset of
b-catenin target genes in colon cancer cells.
DISCUSSION
Gene expression is rarely controlled by the association of a
single transcription factor with an enhancer element
embedded in the proximal promoter. Rather, association
of multiple transcription factors within an enhancer allows
for precise and speciﬁc regulation of gene expression in
response to environmental stimuli. Moreover, enhancers
can occupy regions over 100kb from their target gene
(44,45). Genome-wide proﬁling of transcription factor
binding sites has emerged as one method to localize com-
posite enhancer elements that integrate upstream signal
transduction pathways (17,45). In this report, we used
ChIP-Seq to identify b-catenin enriched regions in
human colon cancer cells. Through an integrated
approach involving bioinformatics, ChIP and expression
analyses, we provide evidence that a population of
b-catenin target genes is directly regulated by b-catenin,
TCF4 and AP-1 transcription factors.
The nature of ChIP-Seq data provides many challenges
for analysis (18). Algorithms have been designed to assign
a presence or absence prediction for occupancy at any
non-repetitive region of the genome. A common
approach for many algorithms is to use sliding window
methods that identify regions of high read depth (relative
to a background distribution) by traversing the genome in
windows of a predetermined size. CisGenome, SISSRs
and WTD algorithms exemplify this approach (24–26).
It follows that although each algorithm ﬁnds disparate
numbers of enriched regions, increased conﬁdence can
be assigned to regions that have been found by all three.
This approach resulted in 2168 enriched b-catenin binding
regions identiﬁed in our b-catenin ChIP-Seq library. In
addition to the three WREs that control MYC expression
(14,22,29), 30 Wnt/b-catenin target genes listed on the
Wnt homepage (http://www.stanford.edu/ rnusse/
pathways/targets.html) were in proximity to b-catenin
enriched regions (Supplementary Table S5).
Furthermore, when considering of all genomic regions
identiﬁed and assayed for b-catenin and TCF4 binding
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Figure 6. A subset of target genes associated with b-catenin enriched
regions containing TCF4 and AP-1 motifs are activated by mitogen and
Wnt signaling. (A) Real-time PCR analysis of cDNAs synthesized from
RNAs isolated from asynchronously growing HCT116 cells. Primers
were designed to spliced exons of the indicated genes that contained
AP-1 and TCF motifs either within or proximal to (<2.5kb) gene
boundaries. Data is presented as expression relative to levels of a
primary tubulin transcript and error is SEM. (B) HCT116 cells were
deprived serum for 2 days and then treated with medium containing
serum in the presence or absence of 10mM LiCl as indicated. RNAs
were isolated, cDNAs reverse transcribed and gene expression analyzed
as in (A). Data is presented as induced expression relative to levels
obtained from serum-deprived cells.
5742 Nucleic Acids Research, 2010,Vol.38, No. 17in this report, we found that 28 of 32 (87.5%) bound both
factors. Together, these ﬁndings indicate that the
b-catenin ChIP-Seq library identiﬁed bona ﬁde and direct
Wnt/b-catenin target genes.
We previously localized b-catenin binding sites in colon
cancer cells using an unbiased and genome-wide approach
termed SACO (14). In that study, we found that 84% of
high conﬁdence b-catenin binding regions contained at
least one TCF4 consensus core motif (T/A–T/A–C–A–
A–A–G). In this report, we performed de novo motif
analysis on the 2168 b-catenin enriched regions and
found that 47% contained a core TCF4 consensus
motif. This discrepancy is likely attributed to methodo-
logical and computational diﬀerences in the generation
and analysis of each data set. For the SACO study, a
5kb interval surrounding the mean position of the
enriched region was used in the analysis. For the
ChIP-Seq analysis, we examined a much smaller interval
enveloping each b-catenin enriched region (600bp).
Therefore, based on our ﬁndings using ChIP-Seq and
due to the resolution of this technique, the 47% associ-
ation rate of TCF4 consensus motifs found in b-catenin
enriched regions likely reﬂects the landscape in vivo.
Results gleaned from our current analysis are consistent
with TCF4 being a predominant factor that directly
recruits b-catenin to enhancers in colon cancer cells, but
also suggest that the portion of targets that rely on other
factors to recruit b-catenin is substantial.
Two recent studies localized TCF4 binding regions in
human colon cancer cells using ChIP-Seq (21,22). We
therefore searched for representation of our b-catenin
enriched regions in the reported TCF4 libraries. Of the
10 conserved TCF4 binding peak regions identiﬁed by
Tuupanen et al. (22), three were identiﬁed in our
b-catenin ChIP-Seq library. This included the peak that
identiﬁed the WRE located 335kb upstream from the
MYC transcription start site. Upon analysis of the
TCF4 ChIP-Seq data sets reported by Blahnik et al. (21)
and the ENCODE Project Consortium, we found that 786
(36.3%) of our b-catenin peak regions overlapped a TCF4
peak region. There are several possibilities for why a
greater percentage of our b-catenin peak regions are not
represented in the aforementioned ChIP-Seq libraries.
Methodological variations, algorithms chosen to assign
peak regions, and cell-type diﬀerences aside, TCF4 is
bound to both transcriptionally active and repressed
genes. As b-catenin is thought to primarily associate
with transcribed genes, a partial overlap of the b-catenin
enriched regions identiﬁed in our study with the TCF4
enriched regions is expected. Furthermore, as mentioned
above, our analysis suggests that the many genes likely
recruit b-catenin independently of TCF4. Most of these
targets are not represented in the TCF4 ChIP-Seq
libraries. Finally, the amount of sequencing required to
identify all of the binding sites represented in a
ChIP-Seq library is debatable (18). Therefore, we would
anticipate that additional sequencing of our library would
undoubtedly identify more of the reported TCF4 peak
regions. Overall, however, the concordance of TCF4 and
b-catenin peaks identiﬁed by three separate groups
independently validates ChIP-Seq as a methodology to
identify direct Wnt/b-catenin target genes.
Upon mapping the b-catenin enriched regions relative
to RefSeq gene boundaries, we found that binding sites
are dispersed through the 50, intragenic, and 30 ends of
gene boundaries. This ﬁnding is in line with previous
genome-wide localization studies of b-catenin and TCF4
binding sites (12,16). We were intrigued by the observation
that several targets contained b-catenin enriched regions
that localized to both 50 and 30 gene boundaries. Based on
our previous work with MYC (15), we tested whether a
chromatin loop was present at two targets that contained
50 and 30 b-catenin enriched regions in the library, CXXC5
and GRHL3. CXXC5 is a zinc ﬁnger containing protein
that inhibits canonical Wnt signaling in response to bone
morphogen protein signaling in neural stem cells (46).
GRHL3 encodes a Grainyhead factor that plays a role in
epidermal barrier formation in the bladder (47).
Substantial levels of b-catenin binding to the 50 and 30
regions of CXXC5 and GRHL3 were detected by ChIP
analysis (Figure 3B and Supplementary Figure S2).
Using the 3C technique, we found that a chromatin loop
accompanied b-catenin binding to 50 and 30 regions of
CXXC5. However, we were unable to detect a chromatin
loop at GRHL3. This ﬁnding suggests that while looping
between separated enhancers may be a prevalent mechan-
ism to coordinate Wnt/b-catenin gene expression,
b-catenin binding to 50 and 30 sites alone is not suﬃcient
for this interaction. We anticipate that 3C coupled with
high throughput sequencing techniques will facilitate iden-
tiﬁcation of target genes that are regulated by distal WREs
via chromatin loops (48,49).
Through de novo motif analysis, we found that nearly
half of the b-catenin enriched regions that contained a
TCF4 consensus motif also contained an AP-1 motif. It
is noted here that AP-1 motifs were also over-represented
in TCF4 bound regions identiﬁed by recent ChIP-Seq and
ChIP-chip analysis (16,21). However, our current study is
the ﬁrst to report over-representation of AP-1 motifs in
b-catenin bound regions. While b-catenin/TCF4 and AP-1
have been shown by others and our group to regulate
target gene expression (36,38,39,50), our ﬁndings here
suggest that target genes regulated by 417 b-catenin
enriched regions may be likewise regulated. Our ChIP
analysis indicated that nearly every region assayed
(95%) containing a TCF4 and AP-1 motif bound c-Jun,
a component of the AP-1 complex. The majority of these
loci showed an additive increase in expression upon the
addition of both LiCl and serum. This analysis suggests
that mitogen and Wnt signaling pathways likely converge
through AP-1 and b-catenin/TCF4 to co-regulate target
gene expression. However, LiCl treatment failed to
enhance mitogen-activated gene expression for several
targets. It is possible that pre-treatment of quiescent
cells with LiCl prior to serum stimulation would sensitize
the system to facilitate detection of pathway cooperation.
Alternatively, AP-1 binding may function to regulate gene
expression in response to a diﬀerent stimulus such as
cytokine signaling or the apoptotic stress response (35).
The application of sequence-based methods to identify
transcription factor binding sites genome-wide is likely to
Nucleic Acids Research, 2010,Vol.38, No. 17 5743persist as the methodology of choice. Next generation
sequencing technology, such as those using the Illumina
platform, allows increased resolution and increased
output. These attributes have facilitated the replacement
of SACO with massively parallel sequencing approaches
to map transcription factor binding regions isolated by
ChIP. Through our ChIP-Seq screen of b-catenin
binding regions in asynchronous HCT116 cells, we un-
covered evidence for a functional interplay between
b-catenin/TCF4 and AP-1. Because cells that initiate
colon carcinogenesis contain pathogenic levels of
b-catenin in the nucleus and are bathed in serum
mitogens, our ﬁndings here suggest that miss-expression
of target genes containing AP-1 and TCF4 motifs might
represent the pathogenically relevant set.
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